XML 53 R37.htm IDEA: XBRL DOCUMENT v3.20.2
Acquisition of Praha Vaccines a.s. - The unaudited pro forma financial information (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Business Acquisition [Line Items]          
Net income from the acquisition date through June 30, 2020 $ 1,800        
Revenue   $ 35,538 $ 3,357 $ 38,915 $ 7,339
Net loss   $ (18,196) $ (42,119) $ (45,821) $ (87,367)
Basic and diluted net loss per share   $ (0.31) $ (0.97) $ (0.83) $ (2.08)
General and administrative [Member]          
Business Acquisition [Line Items]          
Costs related to the acquisition   $ 1,900